Alaunos Therapeutics Inc (TCRT): Great day again

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	385
Posts	24057
Boards Moderated	1
Alias Born	06/08/2010

Planopenny

Re: None

Thursday, 02/04/2021 11:08:25 AM

Thursday, February 04, 2021 11:08:25 AM

Great day again

Change everything you see, everything you see changes you

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TCRT News

Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:46:36 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:44:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:05:27 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:43:20 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:58:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:45:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:47:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:30:50 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:25:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:00:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 01:00:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 12:30:01 PM
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives • GlobeNewswire Inc. • 11/14/2023 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:34:33 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/01/2023 04:20:04 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:37:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:16:29 PM
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 08/14/2023 08:05:34 PM
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies • GlobeNewswire Inc. • 06/29/2023 11:00:53 AM
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting • GlobeNewswire Inc. • 05/25/2023 09:00:52 PM
Alaunos Therapeutics Reports First Quarter 2023 Financial Results • GlobeNewswire Inc. • 05/10/2023 11:00:17 AM

More TCRT News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover